[Federal Register Volume 83, Number 227 (Monday, November 26, 2018)]
[Notices]
[Pages 60427-60428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25589]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)-RFA-IP-19-001, Surveillance for
Respiratory Syncytial Virus (RSV) and Other Viral Respiratory
Infections Among Native Americans/Alaskan Natives; RFA-IP-19-002,
Increasing Influenza and Tdap Vaccination of Pregnant Women in
Obstetric/Gynecologic Practices in Large Health Systems through Quality
Improvement Interventions; and RFA-IP-19-003, Understanding and
Improving Immunization Services Among Adult Hospital Inpatient and
Observation/Clinical Decision Unit Settings.
Date: March 19-20, 2019.
Time: 10:00 a.m.-5:00 p.m., (EST).
Place: Teleconference, Centers for Disease Control and Prevention,
Room 1080, 8 Corporate Square Blvd., Atlanta, GA 30329.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road, NE, Mailstop E60,
Atlanta, Georgia 30329, (404) 718-8833, [email protected].
The Chief Operating Officer, Centers for Disease Control and
Prevention, has
[[Page 60428]]
been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-25589 Filed 11-23-18; 8:45 am]
BILLING CODE 4163-18-P